FDA halts Advant Pharmaceuticals from selling 50 unapproved products – Cough and Cold Medications

I made a quick visit to the website to see if there was a listing of products and the website for Cough and Cold products is under construction.

WASHINGTON - Federal regulators have secured a court order barring a New Jersey pharmaceutical company from distributing more than 50 unapproved cough and cold medicines.

The Food and Drug Administration said Friday that East Windsor, N.J.-based Advent Pharmaceuticals continued to market the medications despite prior warnings from regulators. The company also failed to correct numerous manufacturing problems identified by FDA inspectors.

The unapproved products marketed by Advent and its subsidiary Neilgen Pharmaceuticals include: BP Allergy Junior Suspension, RE All 12 Suspension and many others.